ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,168.83
-0.06%
S&P 500
5,702.55
-0.19%
Dow Jones
42,063.36
0.09%
US Dollar vs Yen
143.825
0.01%
Brent Oil
74.135
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. ヨーロッパ
  5. EU
  6. Pharming Group NV (PHARM)

  7. Pharming Group NV (PHARM) ニュース

PHARM

Pharming Group NV (PHARM)

Pharming Group NV
から:
次の項目別のソート:
 Showing the most relevant articles for your search:EU:PHARM
日付受信時刻ニュースソース見出しコード企業名
2024/09/0414 : 00GlobeNewswire Inc.Pharming Group to participate in September investor conferencesEU:PHARMPharming Group NV
2024/08/0114 : 00GlobeNewswire Inc.Pharming Group reports second quarter and first half 2024 financial results and provides business updateEU:PHARMPharming Group NV
2024/07/1815 : 00GlobeNewswire Inc.Pharming Group to report second quarter and first half 2024 financial results on August 1EU:PHARMPharming Group NV
2024/06/0315 : 00GlobeNewswire Inc.Pharming Group to participate in June investor conferencesEU:PHARMPharming Group NV
2024/06/0315 : 00GlobeNewswire Inc.Pharming Group to participate in June investor conferencesEU:PHARMPharming Group NV
2024/05/3105 : 44GlobeNewswire Inc.Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European UnionEU:PHARMPharming Group NV
2024/05/2200 : 30GlobeNewswire Inc.Pharming Group reports on results of the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
2024/05/2200 : 30GlobeNewswire Inc.Pharming Group reports on results of the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
2024/05/2015 : 00GlobeNewswire Inc.Pharming Group to participate in May investor conferenceEU:PHARMPharming Group NV
2024/05/2015 : 00GlobeNewswire Inc.Pharming Group to participate in May investor conferenceEU:PHARMPharming Group NV
2024/05/1514 : 00GlobeNewswire Inc.Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
2024/05/0814 : 00GlobeNewswire Inc.Pharming Group reports first quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
2024/05/0814 : 00GlobeNewswire Inc.Pharming Group reports first quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
2024/04/2415 : 00GlobeNewswire Inc.Pharming Group to report first quarter 2024 financial results on May 8EU:PHARMPharming Group NV
2024/04/2414 : 00GlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
2024/04/2414 : 00GlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
2024/04/2001 : 43GlobeNewswire Inc.Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
2024/04/1822 : 04GlobeNewswire Inc.Pharming Group announces the placement of €100 million convertible bonds due 2029EU:PHARMPharming Group NV
2024/04/1815 : 00GlobeNewswire Inc.Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
2024/04/0814 : 00GlobeNewswire Inc.Pharming announces completion of enrollment in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
2024/04/0814 : 00GlobeNewswire Inc.Pharming announces completion of enrollment in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
2024/04/0415 : 30GlobeNewswire Inc.Pharming Group announces the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
2024/04/0414 : 00GlobeNewswire Inc.Pharming Group announces the filing of its 2023 Annual Report and Form 20-FEU:PHARMPharming Group NV
2024/04/0315 : 00GlobeNewswire Inc.Pharming Group to participate in April investor conferencesEU:PHARMPharming Group NV
2024/04/0315 : 00GlobeNewswire Inc.Pharming Group to participate in April investor conferencesEU:PHARMPharming Group NV
2024/03/1415 : 00GlobeNewswire Inc.Pharming Group reports fourth quarter and full year 2023 financial resultsEU:PHARMPharming Group NV
2024/02/2916 : 00GlobeNewswire Inc.Pharming Group to report fourth quarter and full year 2023 financial results on March 14EU:PHARMPharming Group NV
2024/02/2916 : 00GlobeNewswire Inc.Pharming Group to report fourth quarter and full year 2023 financial results on March 14EU:PHARMPharming Group NV
2024/02/0816 : 00GlobeNewswire Inc.Pharming Group to participate in February investor conferencesEU:PHARMPharming Group NV
2024/02/0816 : 00GlobeNewswire Inc.Pharming Group to participate in February investor conferencesEU:PHARMPharming Group NV
 Showing the most relevant articles for your search:EU:PHARM

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
FX
USDGBP
US Dollar vs Sterling
NYSE
VZ
Verizon Communications
CCOM
US100
US Tech 100
NASDAQ
TSLA
Tesla
NYSE
AXP
American Express
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
NASDAQ
AAPL
Apple
COIN
XRPUSD
Ripple
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
COIN
ADAUSD
Cardano
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有